HONG KONG, April 26, 2018 /PRNewswire/ -- Innovent Biologics, Inc., a leading biotech company in China, is pleased to announce the completion of its US$150 million Series E round financing.
Growth Capitalist (https://growthcapitalist.com/2018/04/innovent-biologics-completed-us150-million-series-e-round-financing/)
HONG KONG, April 26, 2018 /PRNewswire/ -- Innovent Biologics, Inc., a leading biotech company in China, is pleased to announce the completion of its US$150 million Series E round financing.